Brian M. Murray MD
Brian M. Murray
MD
Vice Chair of Clinical Affairs, Department of Medicine, Associate Professor
Jacobs School of Medicine & Biomedical Sciences
Specialty/Research Focus
Internal Medicine; Nephrology
Contact Information
Patient Care
Patient Care
This faculty member is affiliated with UBMD, practicing physicians who are also professors in the Jacobs School.
View this physician on UBMDProfessional Summary:
My clinical activities are focused on caring for patients with chronic kidney disease (CKD) and those with end-stage renal disease undergoing renal replacement therapy. I am the Chief Medicine at Erie County Medical Center (ECMC) as well as the Vice Chair for Clinical Affairs for the UB Department of Medicine..
Mycurrent research involves a collaborative project with the School of Pharmacy on the effects of age, gender, race on the handling of immunosuppressive medications used to prevent rejection of kidney transplants.
Education and Training:
- Fellowship, Renal, University of Minnesota Hospitals (1985)
- Residency, Internal Medicine, Trinity College, University of Dublin (1982)
- Internship, Internal Medicine, Trinity College, University of Dublin, Meath Hospital (1980)
- MD, Medicine, Surgery, Obstetrics and Gynecology, Trinity College, University of Dublin (1979)
- BA, Biochemistry, Trinity College (1976)
Employment:
- Chief of Medicine, Erie County Medical Center (2024-present)
- Vice Chair for Clinical Affairs, Medicine, JSMBS Department of Medicine (2024-present)
- Interim Director, Transplant and Renal Center of Excellence, Erie County Medical Center (2011-present)
- Chief Medical Officer, Erie County Medical Center (2008-present)
- Associate Professor of Medicine, Medicine, University at Buffalo Jacobs School of Medicine & Biomedical Sciences (1994-present)
- Attending in Internal Medicine & Nephrology, Erie County Medical Center (1985-present)
- Attending Physician, Internal Medicine, Erie County Medical Center (1985-present)
- Interim Chair, Department of Medicine, Medicine, Jacobs School of Medicine & Biomedical Sciences (2023–2024)
- Interim President & CEO, UBMD Internal Medicine (2023–2024)
- Chief Medical Officer, Administration, Erie County Medical Center (2008–2022)
- Interim Program Director: ECMC Multi-Organ Transplant Program, Erie County Medical Center (2011–2015)
- Consultative Staff, South Buffalo Mercy Hospital (1985–2013)
- Associate Medical Director, Erie County Medical Center (2004–2008)
- Associate Medical Director, Administration, Erie County Medical Center (2004–2008)
- Medical Director, Clevehill Dialysis Unit (1996–2004)
- Medical Director, Hemodialysis Unit, Erie County Medical Center (1989–2004)
- President, Medical/Dental Staff, Erie Country Medical Center (2000–2002)
- Assistant Professor of Medicine, Medicine, University at Buffalo Jacobs School of Medicine & Biomedical Sciences (1985–1994)
- Acting Director, Hemodialysis Unit, Erie Country Medical Center (1988–1989)
- Research Assistant Professor, Medicine, University at Buffalo Jacobs School of Medicine & Biomedical Sciences (1986–1989)
- Part-Time Staff Physician (Emergency Room), University of Minnesota Hospitals (1984–1985)
Awards and Honors:
- Who's Who in Healthcare (2012)
- ECMC's Distinguished Physician Award (2010)
- Best Doctors in America (2007)
- Best of the Best Award, Region‘s Highest Health Care Honor (2004)
- Gift of Life Award, National Kidney Foundation of WNY (2004)
- Fellowship of the American College of Physicians (1995)
- Fellowship of the Royal College of Physicians of Ireland (1995)
- Travel Fellowship to the X International Congress of Nephrology, London, England (1987)
- Scientific Achievement Award (1984)
- Sir James Craig Memorial Prize (1st Place) in Medicine, Trinity College in Dublin (1979)
- Gold Medal and Moderatorship Prize (1st Place) in the Faculty of Natural Sciences, Trinity College in Dublin (1976)
- Castle Connolly‘s Top Doctors in America
UB 2020 Strategic Strengths:
- Health and Wellness Across the Lifespan
Grants and Sponsored Research:
- August 2019–December 2025
Age and Race Influences on Immunosuppression after Renal Transplant:
National Institute of Aging
Role: Co-Investigator
$3,500,000
Journal Articles:
- Brazeau D , Attwood K, Cooper, LM; Gray, V, Chang S, Chen, S, Murray, BM; Tornatore KM. (2025) Association of Metabolic Genotype Composite CYP3A5*3 and CYP3A4*1B to Tacrolimus Pharmacokinetics in stable Black and White Kidney Transplant Recipients. Clinical and Translational Science (Oct), 18(10): e70370.. doi:https://doi.org/10.1111/cts.70370
- Nguyen TD, Smith NM, Attwood K, Gundroo A, Chang S, Yonis M, Murray B, Tornatore KM. (2023) Bayesian optimization of tacrolimus exposure in stable kidney transplant patients. Pharmacotherapy (Oct), 43(10): 1032-1042. doi:10.1002/phar.2848
- Tornatore KM, Attwood K, Venuto RC, Murray B. (2023) Age associations with tacrolimus and mycophenolic acid pharmacokinetics in stable Black and White kidney transplant recipients: Implications for health inequities. Clinical and translational science (May), 16(5): 861-871. doi:10.1111/cts.13495
- Krahn RE, Tulowitzki R, Gudleski GD, Murray B, Rajagopalan B, Su W, Muscarella M, Lambert J, Curits AB, Panesar M. E. (2019) Effect of Bicarbonate-Buffered Dialysate on Ventricular Arrythmias in Hemodialysis Patients. American Journal of Nephrology 49: 74-80 , 2019. American Journal of Nephrology (Jan), 49(January): 74-80. doi:10.1159/000495846
- Panesar M, Shah N, Vaqar S, Ivaturi K, Gudleski G, Muscarella M, Lambert J, Su W, Murray B. (2017) Changes in Serum Bicarbonate Levels Caused by Acetate-Containing Bicarbonate-Buffered Hemodialysis Solution: An Observational Prospective Cohort Study. Ther Apher Dial (Mar).
- Arora P, Elkin PL, Eberle J, Bono JJ, Argauer L, Murray BM, Ram R, Venuto RC. (2015) An Observational Study of the Quality of Care for Chronic Kidney Disease: A Buffalo and Albany, New York Metropolitan Area Study. BMC Nephrology (Dec), 16: 199-199.
- Murray BM, M. Panesar, N. Shah, V. Shah, K. Ivaturiu, G. Gudleski, M. Muscarella, J. Lambert, W. Su. (2015) Therapeutic Apheresis and Dialysis. Therapeutic Apheresis and Dialysis (Jan)157-165.
- Vaqar S, Murray B, Panesar M. (2014) The medical-legal responsibilities of a dialysis unit medical director. Seminars in dialysis (Jan), 27(5): 472-6.
- Nainani N, Patel N, Tahir N, Kumar R, Weber-Shrikant E, Gundroo AA, Murray BM, Tornatore KM, Blessios GA, Venuto RC. (2012) Effect of Steroid-Free Low Concentration Calcineurin Inhibitor Maintenance Immunosuppression Regimen on Renal Allograft Histopathology and Function. Nephrology Dialysis Transplantation (May), 27(5): 2077-2083.
- Panesar M, Boateng F, Patel SS, Masood SF, Mahajan P, Patel N, Murray B. (2010) Transmetallation and Gadolinium: Do Low Iron Stores Prevent the Development of Nephrogenic Systemic Fibrosis in High-risk End-stage Renal Disease Patients?. Hemodialysis International (Jul), 14(3): 289-294.
- Abreo K, Allon M, Asif A, Atray N, Besarab A, Dember LM, Dixon BS, DeVita M, Kaufman J, Murray BM, Nguyen VD, Paulson WD, Ram SJ, Vachharajani T, Vesely TM, White JJ, Work J, Kennedy J. (2010) Which Direction is Right for Vascular Access Surveillance? A Debate. Nephrol News Issues (Jun), 24(7): 30 32 34-30 32 34.
- Fox CH, Swanson A, Kahn LS, Glaser K, Murray BM. (2008) Improving Chronic Kidney Disease Care in Primary Care Practices: An Upstate New York Practice-based Research Network (UNYNET) Study. J Am Board Fam Med (Nov), 21(6): 522-530.
- Fox CH, Voleti V, Kahn LS, Murray B, Vassalotti J. (2008) A Quick Guide to Evidence-based Chronic Kidney Disease Care for the Primary Care Physician. Postgrad Med (Jul), 120(2): 1-6.
- Maddux FW, Shetty S, del Aguila MA, Nelson MA, Murray BM. (2007) Effect of Erythropoiesis-stimulating Agents on Healthcare Utilization, Costs, and Outcomes in Chronic Kidney Disease. Ann Pharmacother (Nov), 41(11): 1761-1769.
- Singh N, Ahmad S, Wienckowski JR, Murray BM. (2006) Comparison of Access Blood Flow and Venous Pressure Measurements as Predictors of Arteriovenous Graft Thrombosis. J Vasc Access (Apr), 7(2): 66-73.
- Murray BM, Herman A, Mepani B, Rajczak S. (2006) Access Flow After Angioplasty Predicts Subsequent Arteriovenous Graft Survival. J Vasc Interv Radiol (Feb), 17(2 Pt): 303-308.
- Fox CH, Brooks A, Zayas LE, McClellan W, Murray B. (2006) Primary Care Physicians‘ Knowledge and Practice Patterns in the Treatment of Chronic Kidney Disease: An Upstate New York Practice-based Research Network (UNYNET) Study. J Am Board Fam Med (Jan), 19(1): 54-61.
- Murray BM, Malireddi K, Vavilala V. (2005) Delivery of Predialysis Care in an Academic Referral Nephrology Practice. Ren Fail (Jan), 27(5): 571-580.
- Murray BM, Rajczak S, Herman A, Leary D. (2004) Effect of Surgical Banding of a High-flow Fistula on Access Flow and Cardiac Output: Intraoperative and Long-term Measurements. Am J Kidney Dis (Dec), 44(6): 1090-1096.
- Murray BM. (2004) Screening for Prophylactic Intervention in Failing Hemodialysis Grafts and Fistulas. Saudi J Kidney Dis Transpl (Jul), 15(3): 305-320.
- Murray BM, Subramaniam S. (2004) Late Cytomegalovirus Infection after Oral Ganciclovir Prophylaxis in Renal Transplant Recipients. Transpl Infect Dis (Mar), 6(1): 3-9.
- Arbabzadeh M, Mepani B, Murray BM. (2002) Why do Grafts Clot Despite Access Blood Flow Surveillance?. Cardiovasc Intervent Radiol (Nov), 25(6): 501-505.
- Tornatore KM, Garey KW, Saigal N, Reed K, Murray BM, Ingalls E, DiFrancesco R, Forrest A, Morse GD, Venuto RC, Morse GD. (2001) Ganciclovir Pharmacokinetics and Cytokine Dynamics in Renal Transplant Recipients with Cytomegalovirus Infection. Clinical Transplantation (Oct), 15(5): 297-308.
- Murray BM, Rajczak S, Ali B, Herman A, Mepani B. (2001) Assessment of Access Blood Flow After Preemptive Angioplasty. Am J Kidney Dis (May), 37(5): 1029-1038.
- Rubin RH, Kemmerly SA, Conti D, Doran M, Murray BM, Neylan JF, Pappas C, Pitts D, Avery R, Pavlakis M, Del Busto R, DeNofrio D, Blumberg EA, Schoenfeld DA, Donohue T, Fisher SA, Fishman JA. (2000) Prevention of Primary Cytomegalovirus Disease in Organ Transplant Recipients with Oral Ganciclovir or Oral Acyclovir Prophylaxis. Transpl Infect Dis (Sep), 2(3): 112-117.
- Murray BM, Brown GP, Schoenl M. (1998) Interaction of Gender and Dietary Protein on Renal Growth and the Renal Growth Hormone-Insulin-like Growth Factor Axis. J Lab Clin Med (Apr), 131(4): 360-369.
- Murray BM, Amsterdam D, Gray V, Myers J, Gerbasi J, Venuto R. (1997) Monitoring and Diagnosis of Cytomegalovirus Infection in Renal Transplantation. Journal of the American Society of Nephrology (Sep), 8(9): 1448-1457.
- Murray BM. (1997) Management of Cytomegalovirus Infection in Solid-organ Transplant Recipients. Immunol Invest (Jan), 26(1-2): 243-255.
- Evans, M. J., Edwards-Spring, Y., Myers, J., Wendt, A., Provinelli, D., Daniel Amsterdam, Rittenhouse-Diakun, K., Armstrong, D., Murray, B. M., Greenberg, S. J., Riepenhoff-Talty, M. (1997) Polymerase Chain Reaction Assays for the Detection of Cytomegalovirus in Organ and Bone Marrow Transplant Recipients. Immunological Investigation (Jan), 26(1&2): 209-229.
- Tornatore KM, Biocevich DM, Reed KA, Tousley K, Gray V, Singh JP, Murray BM, Venuto RC, Tornatore-Morse KM. (1995) Post-Transplant Diabetes Mellitus and Methylprednisolone Pharmacokinetics in African-American and Caucasian Renal Transplant Recipients. Clinical Transplantation (Aug), 9(4): 289-296.
- Murray BM, Brentjens J, Amsterdam D, Myers J, Gray V, Pawlowski I, Schewegler K, Singh JP, Venuto RC. (1994) The Cytomegalovirus-Antigenemia Assay in the Diagnosis of Posttransplant Cytomegalovirus Infection. Journal of the American Society of Nephrology (Feb), 4(8): 1615-1622.
- Murray BM, Campos SP, Schoenl M, MacGillivray MH. (1993) Effect of Dietary Protein Intake on Renal Growth: Possible Role of Insulin-like Growth Factor-I. J Lab Clin Med (Dec), 122(6): 677-685.
- Frankel D, Dolgin J, Murray BM. (1993) Non-traumatic Rhabdomyolysis Complicating Antihistamine Overdose. J Toxicol Clin Toxicol (Jan), 31(3): 493-496.
- Murray BM. (1990) Effect of Protein Intake on Regional Vascular Resistance and Reactivity to Angiotensin II in the Rat. Circ Res (Aug), 67(2): 440-447.
- Murray BM, Venuto RC, Kohli R, Cunningham EE. (1990) Enalapril-Associated Acute Renal Failure in Renal Transplants: Possible Role of Cyclosporine. American Journal of Kidney Diseases (Jul), 16(1): 66-69.
- Murray BM, Brown GP. (1990) Effect of Protein Intake on the Autoregulation of Renal Blood Flow. Am J Physiol (Jan), 258(1 Pt): 168-174.
- Murray BM, Paller MS. (1986) Pressor Resistance to Vasopressin in Sodium Depletion, Potassium Depletion, and Cirrhosis. Am J Physiol (Sep), 251(3 Pt): 525-530.
- Murray BM, Paller MS. (1986) Beneficial Effects of Renal Denervation and Prazosin on GFR and Renal Blood Flow After Cyclosporine in Rats. Clin Nephrol (Jan), 25 Su: 37-39.
- Murray BM, Paller MS, Ferris TF. (1985) Effect of Cyclosporine Administration on Renal Hemodynamics in Conscious Rats. Kidney Int (Nov), 28(5): 767-774.
- Murray BM, Paller MS. (1985) Decreased Pressor Reactivity to Angiotensin II in Cirrhotic Rats. Evidence for a Post-receptor Defect in Angiotensin Action. Circ Res (Sep), 57(3): 424-431.
- Paller MS, Murray BM. (1985) Renal Dysfunction in Animal Models of Cyclosporine Toxicity. Transplant Proc (Aug), 17(4 Sup): 155-159.
Evaluative Studies and Case Reports:
- Liu L, Murray B, Tomaszewski J. (2021) Lupus podocytopathy superimposed on diabetic glomerulosclerosis: A case report. Medicine (Baltimore) (Sep), 100(September): e27077.. doi:10.1097/MD.0000000000027077.
Professional Memberships:
- American Medical Association (2015–present)
- Renal Physicians Association (2001–present)
- Royal College of Physicians of Ireland (Fellow); Fellow (1995–present)
- American Society of Transplant Physicians; 2004-2006, Member, Patient Care Committee & Education 2004-2007, Member, Pancreas Kidney Committee (1989–present)
- American College of Physicians (Fellow) (1987–present)
- National Kidney Foundation; 1992-2005, Chair, Medical Advisory Board, WNY 1992-2006, Board Member, WNY 2004, Member, special Task Force on Chronic Kidney Disease (1987–present)
- International Society of Nephrology (1985–present)
- American Society of Nephrology (1985–present)
Presentations:
- "Bones of contention - management of bone disease in stage 3 CKD" Western New York CKD Symposium (2010)
- "Good drugs gone bad - from biologicals to bikes" Roswell Park Medical Club (2008)
- "Perils of prescribing in CKD" Western New York CKD Symposium (2008)
- "Perils of prescribing in CKD" Western New York CKD Symposium (2007)
- "Identification and management of CKD in primary care: chipping away at the iceberg" World Kidney Day Symposium (2006)
- "Bones of contention - management of bone disease in stage 3 CKD" Western New York CKD Symposium (2005)
- "Chronic kidney disease in Western New York" Western New York CKD Symposium (2005)
- "Identification and management of CKD in primary care: chipping away at the iceberg" Annual Meeting of the End Stage Renal Network of New York (2005)
- "Identification and management of CKD in primary care: the Western New York project" National Renal Administrator's Association National Meeting (2005)
- "Managing CKD: a nephrologist-pcp joint venture" Western New York CKD Symposium (2004)
- "The CKD epidemic - silent but deadly" Roswell Park Medical Club; Roswell Park Medical Club (2003)
Service Activities:
- Monthly meeting with Chair; Division Chiefs and Vice Chairsmeeting (2024–present)
- UBMD Internal Medicine; Vice Chair of Clinical Affairs (2024–present)
- Dean's UBMD Advisory Group Meeting; Member (2023–2025)
- Department of Medicine; Member (2023–2024)
- Monthly Chairs Meeting; Interim Chair (2023–2024)
- UBA Practice Plan Meeting; Member (2023–2024)
- Faculty SEnate; Member (2023–present)
- Faculty Council; Member (2023–present)
- Review of Practice Plan billing practices; Monthly Billing Meeting (2023–present)
- Review of Practice Plan finances; Monthly Financial Meeting (2023–present)
- WNY Covid Research Collaborative ( now Rethink WNY Collaborative Steering Committee); Member (2020–2022)
- Irish Classical Theater; Board Member (2017–2023)
- ; CTSI Board (2017–2024)
- Physicians Advisory Council Healthelink Buffalo NY; Committee member (2017–2022)
- Kidney Foundation of Western New York; Board Member (2016–present)
- IPRO ESRD Network 2; Member (2012–present)
- Graduate Medical Education Committee; Member (2008–2022)
- IPRO ESRD Network; Medical Advisory Board (2004–present)